Stock RV6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Real-time Estimate Tradegate
Other stock markets
 03:24:06 2024-06-07 pm EDT 		5-day change 1st Jan Change
199.3 EUR -2.10% Intraday chart for Charles River Laboratories International, Inc. +5.19% -4.23%
02:51pm The job report just threw a spanner in the works Our Logo
11:38am Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Charles River Laboratories Expands Access to CRADL Contract Vivarium Space in Somerville
AQ
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
BU
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
BU
Charles River Laboratories to Present at William Blair and Jefferies Conferences
BU
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
BU
Charles River: Q1 Earnings Snapshot
AQ
Charles River Laboratories Announces First-Quarter 2024 Results
BU
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
BU
Charles River Laboratories International : Proxy Supplement Filed April 24, 2024
PU
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
BU
Charles River Laboratories International : 2023 Corporate Citizenship Report
PU
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
BU
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
AQ
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
BU
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
BU
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
BU
Charles River to Perform Plasmid Production for Ship of Theseus
BU
Charles River to Perform Plasmid Production for Ship of Theseus
BU
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
BU
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. News Charles River Laboratories International, Inc.
  6. Press Releases